Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 449

Results For "Mark"

5335 News Found

Bruker releases CCS-Enabled TIMScore and TIMS DIA-NN 4D Proteomics Software
Biotech | March 01, 2022

Bruker releases CCS-Enabled TIMScore and TIMS DIA-NN 4D Proteomics Software

Innovative TIMScore for dda-PASEF and dia-PASEF libraries, combined with TIMS DIA-NN identifies 9000 protein groups from 200 ng K562 lysate in just 35 min gradient


Synapse Medicine raises US $ 28 million to scale its medication reconciliation platform
Startup | March 01, 2022

Synapse Medicine raises US $ 28 million to scale its medication reconciliation platform

The company, already scaling across Europe, plans to accelerate the deployment of its medication reconciliation platform in the United States


South Korea's OCI acquires 11% stake in Bukwang Pharmaceutical
Biotech | March 01, 2022

South Korea's OCI acquires 11% stake in Bukwang Pharmaceutical

Company has bought 7.73 million shares for KRW 146.1 billion thus securing the largest shareholder status in Bukwang Pharmaceutical


Mankind Pharma completes acquisition of Panacea Biotec’s domestic business for Rs 1872 cr
News | February 28, 2022

Mankind Pharma completes acquisition of Panacea Biotec’s domestic business for Rs 1872 cr

Mankind Pharma has agreed to retain Panacea Biotec’s sales and marketing team engaged in this business


Biocon Biologics acquires Viatris’ biosimilar assets for up to US $ 3.3 billion
News | February 28, 2022

Biocon Biologics acquires Viatris’ biosimilar assets for up to US $ 3.3 billion

BBL will gain Viatris’ global biosimilars business whose revenues are estimated to be USD 1 billion next year, along with its portfolio of in-licensed biosimilar assets


China’s NMPA accepts supplemental NDA for Carteyva
Drug Approval | February 28, 2022

China’s NMPA accepts supplemental NDA for Carteyva

The sNDA was supported by the clinical results from cohort B of a single-arm, multi-center, pivotal study (RELIANCE study) on Carteyva in adult patients with relapsed or refractory B cell non-hodgkin lymphoma in China


Unichem receives ANDA approval for bipolar disorder drug
Drug Approval | February 28, 2022

Unichem receives ANDA approval for bipolar disorder drug

Divalproex Sodium Extended-Release tablets are indicated for the treatment of acute manic or mixed episodes associated with bipolar disorder, as monotherapy and adjunctive therapy and prophylaxis of migraine headaches


Europe clears blood test to predict Alzheimer’s disease
Medical Device | February 28, 2022

Europe clears blood test to predict Alzheimer’s disease

It is the first approved blood test that can predict likely progression to Alzheimer's Disease up to six years in advance


Mental wellness startup LISSUN opens centre in UP
Startup | February 28, 2022

Mental wellness startup LISSUN opens centre in UP

The company claims that this is the first time a mental wellness start-up has gone phygital in a Tier 2 city


BDR Pharma launches enzalutamide in 160 mg strength
Biotech | February 28, 2022

BDR Pharma launches enzalutamide in 160 mg strength

This medicine was previously available in 40mg and 80mg strength, for which patients had to consume 2 tablets a day as per the approved dosage